Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy

Bernard J. Slater, Fernandino L. Vilson, Yan Guo, Daniel Weinreich, Shelly Hwang, Steven L. Bernstein

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose. Optic nerve (ON) ischemia associated with nonarteric anterior ischemic optic neuropathy (NAION) results in axon and myelin damage. Myelin damage activates the intraneural Ras homolog A (RhoA), contributing to axonal regeneration failure. We hypothesized that increasing extrinsic macrophage activity after ON infarct would scavenge degenerate myelin and improve postischemic ON recovery. We used the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) to upregulate ON macrophage activity, and evaluated GM-CSF's effects after ON ischemia in the NAION rodent model (rAION). Methods. Following rAION induction, GM-CSF was administered via intraventricular injection. Retinal ganglion cell (RGC) stereologic analysis was performed 1 month postinduction. The retinae and optic nerve laminae of vehicle- and GM-CSF-treated animals were examined immunohistochemically and ultrastructurally using transmission electron microscopy (TEM). RhoA activity was analyzed using a rhotekin affinity immunoanalysis and densitometry. Isolated ONs were analyzed functionally ex vivo by compound action potential (CAP) analysis. Results. Rodent NAION produces ON postinfarct demyelination and myelin damage, functionally demonstrable by CAP analysis and ultrastructurally by TEM. Granulocytemacrophage colony-stimulating factor increased intraneural inflammation, activating and recruiting endogenous microglia, with only a moderate amount of exogenous macrophage recruitment. Treatment with GM-CSF reduced postinfarct intraneural RhoA activity, but did not neuroprotect RGCs after rAION. Conclusions. Sudden ON ischemia results in previously unrecognized axonal demyelination, which may have a clinically important role in NAION-related functional defects and recovery. Granulocyte-macrophage colony-stimulating factor is not neuroprotective when administered directly to the optic nerve following ON ischemia, and does not improve axonal regeneration. It dramatically increases ON-microglial activation and recruitment.

Original languageEnglish (US)
Pages (from-to)7952-7961
Number of pages10
JournalInvestigative Ophthalmology and Visual Science
Volume54
Issue number13
DOIs
StatePublished - 2013
Externally publishedYes

Keywords

  • GM-CSF
  • Immune regulation
  • Macrophages
  • Microglia
  • Naion
  • Optic nerve ischemia
  • Postinfarct demyelination
  • Rodent models

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy'. Together they form a unique fingerprint.

Cite this